Strand Life Sciences
Strand Life Sciences is dedicated to solving problems in genomics, precision medicine, and bioinformatics. With over 24 years of domain experience, the company collaborates with clients in healthcare, pharma, diagnostics, and research to develop innovative solutions, software, and platforms that advance genomics and clinical research. Their mission is to enable precision medicine globally through expertise in bioinformatics, laboratory assays, and clinical research, aiming to become a leading 'omics enabling company.
Industries
Nr. of Employees
large (251-1000)
Patents
Apparatuses and methods for determining a patient's response to multiple cancer drugs
US-10734117-B2
View Details
Apparatuses and methods for determining a patient's response to multiple cancer drugs
US-10734117-B2
View DetailsProducts
Automated clinical interpretation and reporting platform
Tertiary-analysis platform that aggregates variant annotations, applies rules-based interpretation, and generates clinician-facing reports with therapy and trial annotations.
Integrated NGS secondary-analysis and visualization platform
Platform for secondary analysis, data management and visualization to support variant calling, QC and downstream interpretation workflows.
Automated qPCR & AST reporting software
Software that ingests qPCR and AST outputs, applies curated rules and produces clinician-ready reports with treatment guidance and audit logging.
Metadata curation portal for single-cell datasets
Portal and tooling to automate metadata ingestion, standardization and annotation for single-cell and spatial datasets, leveraging ML/LLM acceleration.
Variant prioritization and verification tooling
Automated variant prioritization and verification tools that reduce manual review effort and improve diagnostic yield in exome and panel analyses.
Liquid biopsy cfDNA analysis pipeline
End-to-end cfDNA analytic pipeline optimized for ultra-sensitive variant calling and cost-efficient compute execution.
Automated clinical interpretation and reporting platform
Tertiary-analysis platform that aggregates variant annotations, applies rules-based interpretation, and generates clinician-facing reports with therapy and trial annotations.
Integrated NGS secondary-analysis and visualization platform
Platform for secondary analysis, data management and visualization to support variant calling, QC and downstream interpretation workflows.
Automated qPCR & AST reporting software
Software that ingests qPCR and AST outputs, applies curated rules and produces clinician-ready reports with treatment guidance and audit logging.
Metadata curation portal for single-cell datasets
Portal and tooling to automate metadata ingestion, standardization and annotation for single-cell and spatial datasets, leveraging ML/LLM acceleration.
Variant prioritization and verification tooling
Automated variant prioritization and verification tools that reduce manual review effort and improve diagnostic yield in exome and panel analyses.
Liquid biopsy cfDNA analysis pipeline
End-to-end cfDNA analytic pipeline optimized for ultra-sensitive variant calling and cost-efficient compute execution.
Services
Tertiary analysis and clinician-ready reporting from somatic and germline NGS data including therapy annotation and trial linking.
Curation of variant content under recognized interpretation frameworks and delivery of reporting-ready variant databases.
Generation and analysis of validation datasets, LOD/sensitivity/specificity determination and preparation of regulatory-ready documentation for lab accreditation and submissions.
Product development for genomic software including verification/validation of algorithms, clinical-grade documentation and integration with client workflows and LIMS.
Ingestion, standardization and harmonization of heterogeneous RWD sources to build analytics-ready repositories and discovery cohorts for translational research.
Configurable infectious-disease reporting that converts PCR and AST outputs into clinician-ready reports with treatment guidance and LIMS/HL7 integrations.
Tertiary analysis and clinician-ready reporting from somatic and germline NGS data including therapy annotation and trial linking.
Curation of variant content under recognized interpretation frameworks and delivery of reporting-ready variant databases.
Generation and analysis of validation datasets, LOD/sensitivity/specificity determination and preparation of regulatory-ready documentation for lab accreditation and submissions.
Product development for genomic software including verification/validation of algorithms, clinical-grade documentation and integration with client workflows and LIMS.
Ingestion, standardization and harmonization of heterogeneous RWD sources to build analytics-ready repositories and discovery cohorts for translational research.
Configurable infectious-disease reporting that converts PCR and AST outputs into clinician-ready reports with treatment guidance and LIMS/HL7 integrations.
Expertise Areas
- Clinical genomics and diagnostic reporting
- Bioinformatics product and pipeline development
- Assay validation and interlaboratory standardization
- Data harmonization, curation and ontology design
Key Technologies
- Next-generation sequencing (secondary and tertiary analysis)
- Long-read sequencing workflows
- Droplet digital PCR (ddPCR)
- qPCR and antibiotic susceptibility testing reporting
News & Updates
Spotlight on our continued partnership with Celemics to enhance NGS analysis.
A webinar on clinical applications of genomics and bioinformatics.
Strand collaborates with Palisade Bio to advance precision medicine.
Strand's bioinformatics expertise helps develop liquid biopsy assays with cost reduction and high sensitivity.
The platform enables rapid, scalable, and customizable infectious disease testing and reporting.
Ensured correct installation, operation, and performance of the HRD analysis component in the Dragen TSO500 pipeline, meeting IQ, OQ, and PQ standards.
Spotlight on our continued partnership with Celemics to enhance NGS analysis.
A webinar on clinical applications of genomics and bioinformatics.
Strand collaborates with Palisade Bio to advance precision medicine.
Strand's bioinformatics expertise helps develop liquid biopsy assays with cost reduction and high sensitivity.
The platform enables rapid, scalable, and customizable infectious disease testing and reporting.
Ensured correct installation, operation, and performance of the HRD analysis component in the Dragen TSO500 pipeline, meeting IQ, OQ, and PQ standards.